"Allie’s one of the true hustlers on the indies. She’ll be back and better than ever." The aftermath of the injury to the New Jersey wrestler can be viewed here. According to Australian pro wrestler ...

Merck & Co. expects to launch an easier-to-administer version of its blockbuster cancer treatment Keytruda before the end of the year, accelerating the company’s efforts to protect its top ...

Ben Fidler Keytruda likely earned Merck & Co. something close to $29 billion last year. The dominant cancer immunotherapy, which accounts for a little less than half of Merck’s sales, is patent ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other dividend stocks. The year 2024 proved favorable for dividends, even though the Dividend ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other stocks ahead of major AI event that Jim Cramer discussed. In his appearance on Squawk on the ...

WuXi Biologics Cayman Inc. will sell a vaccine facility in Ireland to Merck & Co. for about $500 million as the Chinese company seeks to enhance its margins while continuing to navigate ...

Jan 6 (Reuters) - China's WuXi Biologics (2269.HK), opens new tab said on Monday it will sell its vaccine facility in Ireland to U.S. drugmaker Merck & Co (MRK.N), opens new tab for about $500 ...

The acquisition from Wuxi Biologics, the embattled CDMO named in the BIOSECURE Act, marks another expansion of Merck’s manufacturing operations in Ireland. Facing increasing global pressure, WuXi ...